Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Audrey Nault"'
Autor:
Yohann Rautureau, Marianne Berlatie, Daniel Rivas, Kurunradeth Uy, Alexandre Blanchette, Géraldine Miquel, Marie-Ève Higgins, Mélanie Mecteau, Audrey Nault, Louis Villeneuve, Véronique Lavoie, Gabriel Théberge-Julien, Geneviève Brand, Line Lapointe, Maxime Denis, Camille Rosa, Annik Fortier, Lucie Blondeau, Marie-Claude Guertin, Marie-Pierre Dubé, Éric Thorin, Jonathan Ledoux, David Rhainds, Éric Rhéaume, Jean-Claude Tardif
Publikováno v:
Cardiovascular Research. 119:450-464
Aims The adenylate cyclase type 9 (ADCY9) gene appears to determine atherosclerotic outcomes in patients treated with dalcetrapib. In mice, we recently demonstrated that Adcy9 inactivation potentiates endothelial function and inhibits atherogenesis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59dfde35e0ca79a2cd243bb6960b41ac
https://doi.org/10.1093/cvr/cvac085
https://doi.org/10.1093/cvr/cvac085
Autor:
Nolwenn Merlet, Pierre-Marc Williams, Marc-Antoine Gillis, Mathieu R. Brodeur, Audrey Nault, Marie-Pierre Dubé, Marie-Claude Guertin, Daniel Rivas, Samaneh Samami, Marie-Ève Higgins, Yohann Rautureau, Géraldine Miquel, Geneviève Brand, Eric Rhéaume, Jean-Claude Tardif, Gaétan Mayer, Maria Laura Suarez, Adeline Raignault, Kurunradeth Uy, Philippe Pouliot, Vanessa Deschambault, Rocio Sanchez, Line Lapointe, Sylvie Levesque, David Rhainds, Natacha Duquette, Eric Thorin, Véronique Lavoie, Foued Maafi, Pascale Geoffroy, Mélanie Mecteau
Publikováno v:
Circulation. 138:1677-1692
Background: Pharmacogenomic studies have shown that ADCY9 genotype determines the effects of the CETP (cholesteryl ester transfer protein) inhibitor dalcetrapib on cardiovascular events and atherosclerosis imaging. The underlying mechanisms responsib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab41496510222d5f9118903396de046b
https://doi.org/10.1161/circulationaha.117.031134
https://doi.org/10.1161/circulationaha.117.031134
Autor:
David Rhainds, Eric Rhéaume, Marie-Ève Higgins, M Berlatie, Audrey Nault, Eric Thorin, Jonathan Ledoux, J.C. Tardif, Kurunradeth Uy, Yohann Rautureau, Daniel Rivas, Géraldine Miquel
Publikováno v:
European Heart Journal. 40
Background/Introduction The clinical benefits of the cholesterol ester transfer protein (CETP) inhibitor dalcetrapib are dependent on the ADCY9 gene, which encodes adenylate cyclase (AC) type 9 (AC9). AC9 is one of nine membrane-bound isoforms of AC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03a77f72c2f6e406743420d23119f505
https://doi.org/10.1093/eurheartj/ehz747.0324
https://doi.org/10.1093/eurheartj/ehz747.0324
Autor:
Géraldine Miquel, Vanessa Deschambault, Marie-Claude Guertin, Pascale Geoffroy, Sylvie Levesque, Eric Rhéaume, Mélanie Mecteau, Marie-Ève Higgins, Kurunradeth Uy, Marc-Antoine Gillis, Yohann Rautureau, Samaneh Samami, Foued Maafi, Pierre-Marc Williams, Maria-Laura Suarez, David Rhainds, Adeline Raignault, Mathieu R. Brodeur, Eric Thorin, Rocio Sanchez, Philippe Pouliot, Line Lapointe, Daniel Rivas, Audrey Nault, Jean-Claude Tardif, Natacha Duquette, Geneviève Brand, Marie-Pierre Dubé, Gaétan Mayer
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 38
Pharmacogenomic studies have shown that ADCY9 genotype determines the effects of the cholesteryl ester transfer protein (CETP) inhibitor dalcetrapib on cardiovascular events, atherosclerosis imaging and body weight variation. The underlying mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81298c9158ff02795677114c0c55c4c3
https://doi.org/10.1161/atvb.38.suppl_1.624
https://doi.org/10.1161/atvb.38.suppl_1.624